Admission Date:  [**2114-10-20**]              Discharge Date:   [**2114-10-23**]  Date of Birth:  [**2062-2-3**]             Sex:   F  Service: MEDICINE  Allergies: Adhesive Tape  Attending:[**First Name3 (LF) 3326**] Chief Complaint: Fall  Major Surgical or Invasive Procedure: None  History of Present Illness: Ms. [**Known lastname 19672**] is a 52-year-old woman with non small cell lung cancer of the right lung and mets to brain and left lung currently on Alimta (last dose [**2114-9-27**]), known PEs on lovenox, who initially presented to [**Hospital **] Hospital after a fall, was found to have ?new pulmonary emboli and transferred to [**Hospital1 18**] for further management, and is admitted to the [**Hospital Unit Name 153**] for hypoxic respiratory failure.
She then underwent a chest CTA that demonstrated a left segmental pulm artery PE, small saddle PE, right pleural effusions, and ?right post-obstructive pneumonia.
Head CT was neg per report.
She was was noted to be satting in the mid 90s on a NRB and in the 80s on room air.
Of note, ROS was neg for fevers, chills; positive for np cough.
Workup with CT head and MRI's at outside hospital showed brain lesions.
A CT torso on [**2113-10-14**] showed lung lesions including a right sided lung mass with associated right hilar nodules.
Biopsy of these areas showed adenocarcinoma that was CK7+, TTF-1+ and CK20 negative consistent with non-small cell lung cancer.
TREATMENT: Carboplatin (6 AUC, D1), Paclitaxel (200 mg/m2, D1), Avastin (15mg/kg, D1), every 3 weeks.
Has smoked [**2-3**] pack - 2packs/day since she was 13 years old.
Physical Exam: General Appearance: NAD, Thin/cachectic, oriented x3, sleepy but easily arousable  HEENT: Dry MM, OP clear  Cardiovascular: RRR, no mrg  Respiratory: decreased breath sounds on R side w crackles, L side grossly CTA  Abdominal: Soft, Non-tender, BS+  Extremities: Cool , no [**Location (un) **], no clubbing,  no cyanosis  Neurologic: AOx3   Pertinent Results: Admission Labs: [**2114-10-20**] 04:00AM BLOOD WBC-11.0 RBC-4.01* Hgb-12.3 Hct-36.2 MCV-90 MCH-30.7 MCHC-34.0 RDW-16.2* Plt Ct-263 [**2114-10-20**] 04:00AM BLOOD Neuts-75.0* Lymphs-19.2 Monos-4.5 Eos-0.9 Baso-0.4 [**2114-10-20**] 04:00AM BLOOD PT-13.7* PTT-23.3 INR(PT)-1.2* [**2114-10-20**] 04:00AM BLOOD Glucose-154* UreaN-13 Creat-0.5 Na-137 K-3.6 Cl-97 HCO3-26 AnGap-18 [**2114-10-20**] 04:00AM BLOOD cTropnT-<0.01 [**2114-10-20**] 04:00AM BLOOD Osmolal-295 [**2114-10-20**] 07:42AM BLOOD Type-ART FiO2-40 pO2-65* pCO2-34* pH-7.52* calTCO2-29 Base XS-4 Intubat-NOT INTUBA  Studies: CXR [**10-21**]: IMPRESSION: Total opacification of the right lung due to complete obstruction of the proximal right mainstem bronchus.
The acute change from prior study suggests mucus plugging superimposed to preexisting soft tissue.
Unofficial In-House [**Location (un) **] of OSH CTA: PE thrombus extent is the same, RML and RUL collapse likely [**3-6**] to mass in R mainstem and bronchus intermedium w ?
post-obstructive PNA  Micro: Blood Cx x 2 on [**10-20**]: PENDING   Brief Hospital Course: Ms. [**Known lastname 19672**] is a 52-year-old woman with non small cell lung cancer of the right lung and mets to brain and left lung currently on Alimta (last dose [**2114-9-27**]), known PEs on lovenox, who initially presented to [**Hospital **] Hospital after a fall, was found to have ?new pulmonary emboli who was transferred to [**Hospital1 18**] for further management and admitted to the [**Hospital Unit Name 153**] for hypoxic respiratory failure.
OSH CTA was reviewed demonstrating no change in PE size, and a R-sided post-obstructive PNA with bilateral pleural effusions.
Her Enoxaparin was held and a heparin gtt was started for her PE ppx.
Underwent whole brain radiation in [**2114-11-2**] and developed PEs while on Avastin in [**2114-4-2**].
Medications on Admission: DEXAMETHASONE - 4 mg Tablet - 1 Tablet(s) by mouth once daily ENOXAPARIN - 60 mg/0.6 mL Syringe - 1 Syringe(s) every 12 hrs FOLIC ACID - 1 mg Tablet - 1 Tablet(s) by mouth once a day LEVETIRACETAM [KEPPRA] - (Prescribed by Other Provider) - 1,000 mg Tablet - 1 (One) Tablet(s) by mouth twice a day LORAZEPAM [ATIVAN] - (Prescribed by Other Provider) - 0.5 mg Tab - 1 (One) Tablet(s) by mouth once a day METAPROTERENOL - Dosage uncertain NORTRIPTYLINE - 25 mg Capsule - 1 Capsule(s) by mouth once a day for postherpetic neuralgia NYSTATIN - 100,000 unit/mL Suspension - 1 tablespoon(s) by mouth PRN ONDANSETRON HCL - 8 mg Tablet - 1 Tablet(s) by mouth q12hrs prn  OXYCODONE - 5 mg Tablet - 1 (One) Tab by mouth 3-4 times per day  OXYCODONE [OXYCONTIN] - 10 mg Tablet Sustained Release 12 hr - 1 Tablet(s) by mouth 3x a day per palliative care team PAROXETINE HCL - 20 mg Tablet - 1 Tablet(s) by mouth once a day  PROCHLORPERAZINE MALEATE - 5 mg Tablet - 1 Tablet(s) by mouth every six (6) hours as needed for nausea BISACODYL - (Prescribed by Other Provider) - Dosage uncertain DOCUSATE SODIUM [COLACE] - (Prescribed by Other Provider) - 100 mg Capsule - Capsule(s) by mouth as needed for constipation MAGNESIUM CHLORIDE - 64 mg Tablet, Delayed Release (E.C.)
You have the currently scheduled appointments which you may keep if you so desire: Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern1) 593**], MD Phone:[**0-0-**] Date/Time:[**2114-10-25**] 10:30 Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern1) 11058**], MD Phone:[**Telephone/Fax (1) 22**] Date/Time:[**2114-10-25**] 10:30 Provider: [**Name10 (NameIs) **] [**First Name8 (NamePattern2) **] [**Name8 (MD) **], RN Phone:[**Telephone/Fax (1) 22**] Date/Time:[**2114-10-25**] 12:00
